Cargando…
Cost effective assay choice for rare disease study designs
High throughput assays tend to be expensive per subject. Often studies are limited not so much by the number of subjects available as by assay costs, making assay choice a critical issue. We have developed a framework for assay choice that maximises the number of true disease causing mechanisms ‘see...
Autores principales: | Campbell, Desmond D, Porsch, Robert M, Cherny, Stacey S, Capra, Valeria, Merello, Elisa, De Marco, Patrizia, Sham, Pak C, Garcia-Barceló, Maria-Mercè |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334400/ https://www.ncbi.nlm.nih.gov/pubmed/25648394 http://dx.doi.org/10.1186/s13023-015-0226-9 |
Ejemplares similares
-
Sacral agenesis: a pilot whole exome sequencing and copy number study
por: Porsch, Robert M., et al.
Publicado: (2016) -
Patient complexity and genotype-phenotype correlations in biliary atresia: a cross-sectional analysis
por: Cheng, Guo, et al.
Publicado: (2017) -
Genetic study of congenital bile-duct dilatation identifies de novo and inherited variants in functionally related genes
por: Wong, John K. L., et al.
Publicado: (2016) -
Comparisons of seven algorithms for pathway analysis using the WTCCC Crohn's Disease dataset
por: Gui, Hongsheng, et al.
Publicado: (2011) -
Genetic Analysis of Disheveled 2 and Disheveled 3 in Human Neural Tube Defects
por: De Marco, Patrizia, et al.
Publicado: (2012)